🇺🇸

M&A Activity

· daily

US Merger & Acquisition SEC Filings — October 01, 2026

The October 1, 2026, M&A landscape is dominated by a wave of completed transactions, with 7 of 21 filings reporting closed deals, including the transformative Reverse Morris Trust merger between Gentherm and Modine, and CenterPoint Energy's $2.62 billion divestiture of its Ohio gas utility. A notable trend is the use of complex, non-cash consideration structures, such as Inseego's equity and warrant issuance to Nokia and Sadot Group's contingent convertible preferred stock, indicating a shift toward performance-based deal financing. The SPAC sector shows renewed activity, with Armada Acquisition Corp. II securing shareholder approval for its Ripple Labs combination and Launch Two Acquisition Corp. seeking an extension to avoid liquidation, suggesting a potential revival in the blank-check market. However, significant risks persist, including the non-binding nature of several key milestones for Aureus Greenway Holdings and the declining financial performance of Sangoma Technologies, which is being acquired by B. Riley Financial. The overall sentiment is cautiously positive, with 9 filings carrying a positive sentiment, but 5 filings with mixed or neutral outlooks highlight the execution risks inherent in these transactions.

21 high priority 21 total filings
· daily

US Merger & Acquisition SEC Filings — September 29, 2026

This digest captures a day of intense M&A and SPAC activity on September 29, 2026, revealing a market bifurcated between high-stakes, high-conviction deals and distressed SPACs running out of runway. The most significant capital event is the completion of the $6.3 billion take-private of Global Business Travel Group (Amex GBT) at a 65.1% premium, signaling strong private market conviction in travel tech. However, the SPAC sector is showing severe stress: Bayview Acquisition Corp was forcibly delisted after failing to complete a merger, while Constellation Acquisition Corp I used its 8th of 11 permitted extensions, highlighting a liquidity and deadline crisis for blank-check vehicles. A notable trend is the use of stock as acquisition currency, seen in Sino Green Land Corp's two all-stock deals and Lexeo Therapeutics' mixed cash/stock purchase, suggesting companies are conserving cash amid uncertain markets. The Fox Factory divestiture of Marucci Sports for $225M, despite a $120M loss on sale, represents a strategic pivot to simplify operations and reduce debt. Insider activity is limited in these filings, but the change of control at BEST SPAC I and the director resignation at D. Boral Acquisition I Corp provide governance signals. The forward-looking catalyst calendar is packed with shareholder votes, delisting dates, and business combination deadlines that will determine the fate of several entities in the coming weeks.

20 high priority 20 total filings
· daily

US Merger & Acquisition SEC Filings — September 28, 2026

The US M&A and takeover landscape is dominated by SPAC activity, with 10 of 13 filings involving blank-check companies at various stages of business combinations. Notable de-SPAC completions include GOWell Energy Technology (IPEX) and the imminent Viking-NorthStar close, while high-profile new deals were announced for Astro Digital (Proem) and REDLattice (Bold Eagle), with valuations of $587M and $1.25B respectively. The filings reveal a bifurcated SPAC market: well-capitalized targets with strong revenue growth (Astro Digital 42% CAGR, REDLattice 29% YoY) are attracting committed capital, while others (Crown Reserve, Columbus, Wintergreen, Lakeshore) face repeated extensions and adjournments, signaling execution risk. Financial distress is evident in Cambium Networks' administration sale, and Greenpro's divestiture of six subsidiaries to an insider highlights strategic restructuring. Insider activity is limited but notable: Greenpro's sale to a director and Emmis's sponsor share transfer to a new director. Forward-looking data points to a catalyst-rich Q4 2026 and Q1 2027, with several deals expected to close by year-end. Overall, the market shows selective investor appetite, favoring targets with proven growth and profitability, while weaker SPACs struggle to complete transactions.

13 high priority 13 total filings
· daily

US Merger & Acquisition SEC Filings — September 25, 2026

The US SPAC M&A landscape is showing clear signs of stress and execution risk, with 3 out of 4 filings revealing material delays, regulatory non-compliance, or repeated amendments. NMP Acquisition Corp. and Blue Acquisition Corp. both disclosed extensions to their business combination deadlines, indicating that target companies are struggling to deliver audited financials, a critical de-SPAC hurdle. Future Money Acquisition Corp. received a Nasdaq deficiency notice for late filing, adding delisting risk to its timeline. In contrast, Pinnacle Acquisition Corp. is in a clean, early-stage position post-IPO, actively searching for targets in specialty finance. The aggregate picture suggests a bifurcated market: well-capitalized, newly-listed SPACs are proceeding normally, while older, pre-merger SPACs face mounting operational and regulatory pressures. No period-over-period financial trends (revenue, margins) are available as these are procedural filings without operational data.

4 high priority 4 total filings
· daily

US Merger & Acquisition SEC Filings — September 24, 2026

The US SPAC market is experiencing a surge in activity with three major capital raises and one key merger amendment this week. Black Hawk Acquisition Corp secured a complex $200M+ financing package for its Vesicor Therapeutics combination, though at a high cost with a 15% discount on prepaid advances. Haymaker Acquisition Corp V completed a $295.5M IPO and private placement, signaling strong investor appetite for new SPACs. Live Oak Acquisition Corp VI priced a $200M IPO, adding to the $495.5M in fresh SPAC capital raised this period. UY Scuti Acquisition Corp amended its merger with Isdera Group, setting a $920M valuation and adjusting conversion terms. Columbus Acquisition Corp and ARC Group Securities Acquisition I filed procedural updates with no financial impact. The dominant theme is the continued flow of SPAC capital formation and deal financing, with a notable shift toward costly but necessary financing structures to close pending business combinations.

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — September 22, 2026

Today's M&A digest is dominated by SPAC activity, with five filings involving SPACs either extending deadlines, finalizing business combinations, or liquidating. Notably, Plutonian Acquisition Corp. II announced a $500M deal with an Australian critical minerals firm, and FortuneX entered a $600M merger with a real estate tech platform, while Metal Sky Star Acquisition Corp elected to liquidate, underscoring the uneven success rate. A major oil & gas asset acquisition was completed by Talos Energy ($420M for Gulf of America assets) and a significant software deal saw Progress Software acquire Domo's AI platform for $400M, creating a new entity (Huckleberry.ai) with over $900M in NOLs. Ares Commercial Real Estate's $64M office sale provided cash but eliminated recurring revenue, deepening its pro forma net loss. Insider trading data was sparse, but the absence of insider sales in ongoing SPAC deals may signal management confidence. Across the set, capital allocation favors M&A over dividends or buybacks, and forward-looking statements point to several Q1 2027 deal completions. The overall theme is one of capital churning: cash-rich SPACs and corporates deploying capital into assets, with a few exits via liquidation, suggesting a market still sorting winners from losers.

13 high priority 13 total filings
· daily

US Merger & Acquisition SEC Filings — September 21, 2026

The September 21, 2026 SPAC and M&A filing batch reveals a market characterized by intense time pressure on blank-check companies to finalize business combinations, with multiple extensions, bridge financings, and charter amendments signaling both urgency and resilience. The most material corporate actions include Axos Financial's completion of a $1.9 billion IRA deposit acquisition from Capital One, National CineMedia's $275 million acquisition of Captivate Holdings, and Algorhythm Holdings' transformational acquisition of an energy business accompanied by a CEO change. SPACs are increasingly using creative financing structures—prepaid forward purchase agreements, convertible promissory notes, and equity purchase facilities—to bridge funding gaps and de-risk redemptions, while also extending deadlines to buy time. Insider activity is limited but notable: the CEO dismissal at Algorhythm and the 100% sponsor ownership transfer at Ocean Capital warrant monitoring. Overall, the batch signals a bifurcated market: well-capitalized operating companies executing strategic M&A, while SPACs face a crunch to close deals before termination dates, with several facing imminent deadlines in October 2026.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — September 18, 2026

The September 18, 2026, M&A digest reveals a market bifurcated between high-conviction, well-capitalized deals and distressed SPACs racing against the clock. The standout signal is the **EigenQ/Silicon Valley Acquisition Corp. merger**, which secured a $45M committed convertible note financing (50% funded upfront) and carries a $3B enterprise value, targeting Q4 2026 close—this is the only deal with clear, positive forward momentum and insider board approval. In contrast, the SPAC landscape is under severe time pressure: **WinVest Acquisition Corp.** has only until October 17, 2026, to close a deal (with minimal $30K monthly extension deposits), while **BPGC Acquisition Corp.** pushed its deadline to March 2028, signaling a 'zombie' SPAC dynamic. The **ChampionsGate/Futuremain** $80M all-stock merger introduces cross-border complexity (Korean tax structuring) and a fixed $10/share valuation, offering limited upside arbitrage. On the REIT side, **Elme Communities** is executing a full liquidation, having sold $1.856B in assets (including the $250M Riverside sale), and is on track to close its final two properties by early October—a clear capital return event. **Medalist Diversified REIT** executed a small $5.4M net-lease acquisition via a DST structure, signaling a pivot to tax-advantaged vehicles. The **Melar Acquisition Corp./Everli** deal remains opaque, with no deal terms disclosed, but Everli's asset-light model and union agreement provide a differentiated labor-cost advantage. Period-over-period comparisons are limited as most filings are event-driven 8-Ks, but the aggregate trend shows a market favoring liquidations and capital returns (Elme) over speculative SPAC mergers, with the exception of the high-quality EigenQ deal.

7 high priority 7 total filings
· daily

US Merger & Acquisition SEC Filings — September 17, 2026

The September 17, 2026, M&A filings reveal a market bifurcated between high-conviction, capital-intensive real estate and healthcare transactions and a flurry of SPACs struggling to complete deals or maintain compliance. The most significant capital movement is in industrial real estate, with Rexford Industrial's $1.2B portfolio sale and Surgery Partners' $796.6M hospital divestiture, both reflecting strategic portfolio realignment to optimize balance sheets. The SPAC sector shows clear distress: two SPACs (Bayview, Ribbon) made routine extension payments to buy time, Fifth Era Acquisition received a Nasdaq deficiency notice for low holder count, and Metal Sky Star fired its auditor amid going-concern warnings. The most transformative deal is Lisata Therapeutics' acquisition of Marea, which will effectively reverse-merge into a cardioendocrine pipeline, diluting legacy shareholders by over 97%. Healthy Choice Wellness Corp. is executing a high-risk reverse merger into a data center project with no revenue and a $27.5M working capital deficit, while Predictive Oncology sold its legacy diagnostics business to complete its pivot to GPU-as-a-Service. Period-over-period data is limited in these 8-K filings, but the forward-looking guidance and capital allocation patterns are rich: Rexford is aggressively buying back stock ($505M YTD), while Lisata's $225M PIPE signals strong institutional appetite for the combined entity's pipeline catalysts in Q4 2027.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — September 16, 2026

The September 16, 2026 M&A and takeover landscape is characterized by a wave of portfolio simplification and strategic pivots, with three notable asset sales (Barnwell Industries, BrightSpire Capital, Reliance Global Group) and a major transformation at Identiv/INVE Technologies. The most significant event is the $1.4 billion SPAC merger between ACP Holdings and May Mobility, which, despite being a high-profile autonomous ride-hail play, reveals a stark contrast between its $337 million gross proceeds and its early-stage metrics of only $10 million in revenue and $93 million in cash burn. A concerning pattern emerges among SPACs: two (K&F Growth Acquisition Corp. II and Range Capital Acquisition Corp.) face Nasdaq listing deficiencies, highlighting ongoing structural challenges in the SPAC market. Period-over-period data from BrightSpire Capital shows a mixed outcome—a $60.4 million gain on sale from its $300 million disposition is offset by continued operational losses, with pro forma net loss widening from $13.5 million to $14.3 million for the six months ended June 30, 2026. Insider activity is absent across all filings, limiting one key signal source, but capital allocation trends are clear: companies are monetizing non-core assets to reduce debt and fund growth initiatives, with Reliance Global Group's 8.75x EBITDA multiple on its Montana sale and Identiv's $50 million preferred equity deal providing valuation benchmarks.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — September 15, 2026

The six filings today reveal concentrated SPAC and special-situation M&A activity, with three blank-check companies actively pursuing business combinations, one completed real estate acquisition, and one insider ownership filing. A dominant theme is the growing appetite for AI-related targets: NuCube's microreactor technology (in Launch Two Acquisition) and Bluechip's AI-driven advertising and data-center services (in Flag Ship Acquisition) both target the booming AI infrastructure market. Insider signals show strong sponsor conviction, with investors willing to accept restrictive lock-up terms and non-interest-bearing loans. Capital structures are aggressive, including a 9.990% interest-only loan with a balloon payment. No traditional period-over-period revenue or margin data was filed, limiting trend identification. The landscape points to elevated risk (SPAC failure, debt balloons) but also offers event-driven alpha from successful de-SPAC closes and property redevelopment.

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — September 14, 2026

The current M&A landscape reveals a pronounced dichotomy between active deal-making in the energy, defense, and diagnostics sectors, and a challenging environment for SPACs, with two SPACs resorting to deadline extensions and one terminating a deal entirely. The Ondas Holdings acquisition of GATE Technologies and Veracyte's purchase of Convergent Genomics underscore high-value, strategic plays in defense and precision diagnostics, with substantial earn-out potential. Conversely, the Embrace Change Acquisition Corp. termination and the near-total redemption at Hudson Acquisition I Corp. highlight significant execution risk and capital flight from cash-rich shells. A critical cross-sector pattern emerges: acquisition targets are increasingly tied to performance-based earn-outs and milestone payments, shifting risk and capitalizing on future operational targets. The data also reveals heightened insider activity in the SPAC sector, with key investors signaling confidence by funding extensions and converting loans, while near-total redemptions signal a lack of retail conviction.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — September 11, 2026

The September 11, 2026, filing batch reveals a bifurcated M&A landscape: high-conviction de-SPAC mergers (Cyclerion/Korsana, Athena/Ace Green) are closing with strong shareholder support and significant capital raises, while several SPACs (Ribbon, Quetta, Columbus) are showing signs of distress with massive redemptions, repeated extensions, and adjournments. The most transformative event is New Fortress Energy's restructuring, which extinguished ~$5.7B in debt and created two standalone entities, representing a massive balance sheet repair. A notable cross-border deal emerged with ChampionsGate's $80M EV acquisition of Korean safety diagnostics firm Futuremain, while Volato's amended merger with Aligned Engine at a $500M valuation shows deal terms are being renegotiated upward. The data reveals a clear pattern: SPACs with strong institutional backing and tangible assets are closing successfully, while those without are struggling to maintain trust account balances. Period-over-period comparisons show no revenue trends as most filers are pre-revenue SPACs or restructuring entities, but the capital allocation trends are stark—$475M in new cash for Korsana vs. $36.3M in redemptions draining Ribbon's trust.

19 high priority 19 total filings
· daily

US Merger & Acquisition SEC Filings — September 10, 2026

The September 10, 2026 M&A digest reveals a dynamic landscape: two SPACs (ARC Group, Three Lions) are executing on their capital-raising and business combination mandates, while two healthcare-focused companies (Tarsus, National Healthcare) are actively reshaping their portfolios through strategic acquisitions and divestitures. SurgePays' divestiture of its ClearLine platform for $27.5M in preferred stock, coupled with a put option, is a critical move to regain Nasdaq compliance, highlighting the pressure on small caps to maintain listing standards. The period-over-period data shows a clear trend of companies using M&A to pivot toward higher-growth or core assets, with Tarsus' acquisition of Alkeus Pharmaceuticals adding a Phase 3 asset with significant regulatory designations. However, the mixed sentiment on ARC Group and SurgePays underscores execution and dilution risks. Overall, the digest points to a bifurcated market: strategic buyers with cash are acquiring clinical-stage assets for long-term growth, while distressed or non-compliant companies are using asset sales to shore up balance sheets. The most critical development is ARC Group's $1.09 billion acquisition of Firstborn Top Capital, which, if completed, would be a transformative cross-border deal, but its success hinges on shareholder approval and regulatory clearance.

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — September 09, 2026

The September 9, 2026 filing set reveals a pronounced acceleration in SPAC activity, with three distinct transactions—two new business combination announcements (Daedalus/HubX, Unite/Blue Laser Fusion) and one extension vote (Alchemy)—highlighting a market still actively seeking and completing de-SPAC deals. The successful tender offer and short-form merger of Selectis Health by Black Pearl Equities at $5.75/share (90.93% tendered) demonstrates a clean, fully-cashed-out acquisition, while Barinthus Biotherapeutics' scheme of arrangement marks a completed cross-border take-private with a stock-for-stock exchange. Notably, no filing disclosed specific financial metrics (revenue, margins, or period-over-period comparisons), indicating a data-scarce environment where qualitative signals—such as Point72's $75M investment commitment in HubX and the unqualified audit opinion for Blue Laser Fusion—carry outsized weight. The extension votes (Alchemy to Sept 2027, Andretti to 36 months from IPO) reflect a broader trend of SPACs buying time to secure quality targets, reducing liquidation risk but extending capital lock-up periods. Overall, the digest points to a bifurcated market: high-quality targets attracting institutional backing (HubX, Blue Laser Fusion) versus cash-strapped SPACs (Alchemy, Andretti) relying on extensions to avoid returning capital. Investors should focus on the execution risk of pending deals and the strategic rationale behind take-privates, as financial disclosures remain limited.

6 high priority 6 total filings
· daily

US Merger & Acquisition SEC Filings — September 08, 2026

The US M&A landscape is bifurcated between high-conviction, strategic acquisitions in industrial and defense tech and the ongoing, high-risk search for targets by cash-rich SPACs. A clear theme emerges of capital flowing into energy infrastructure (nuclear, power solutions) and autonomous systems, with acquisitions like Meshflow/HGP ($921M EV) and AEVEX/BlackSea signaling a premium on specialized technology. Conversely, the SPAC sector shows stress, with Cayson Acquisition's deal termination highlighting execution risk, while Andretti and B&R Technology remain in limbo. Period-over-period data reveals strong operational performance at acquired targets, such as Cat Pumps' 35%+ EBITDA margins and GTS's 36% YoY revenue growth, justifying premium valuations. However, the data also flags significant risk at International Stem Cell, where post-divestiture revenues collapsed to just $296K, and at Medalist Diversified REIT, which is effectively liquidating its asset base. The most critical development is the $800M+ nuclear tech deal, which positions the combined entity for massive government and AI-driven data center demand, while the Solaris acquisition of Omega Foundation Services signals a strategic pivot into the high-growth data center EPC market.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — September 04, 2026

This digest covers 15 filings, with a heavy concentration of SPAC activity including IPOs, business combinations, extensions, and compliance issues. The most material M&A events are the completed acquisitions of LivePerson by SoundHound AI and FSC Bancshares by Hawthorn Bancshares, and the combination of USA Rare Earth with Serra Verde. A clear theme is the acceleration of SPAC deadlines and the emergence of post-merger execution risks, particularly for companies like LivePerson, which underwent a going-private transaction. Insider activity is limited, but the appointment of LivePerson's former CFO at SoundHound AI signals integration focus. Capital allocation trends show a shift toward debt-free balance sheets post-merger, while several SPACs face existential risks from Nasdaq non-compliance or going-concern qualifications. The period-over-period data reveals no revenue trends due to the nature of filings, but forward-looking statements from SoundHound AI and Hawthorn Bancshares provide actionable revenue and operational targets.

15 high priority 15 total filings
· daily

US Merger & Acquisition SEC Filings — September 03, 2026

Today's digest captures a surge in SPAC activity, with 8 of 16 filings involving blank-check companies pursuing or finalizing business combinations, signaling robust deal-making in the de-SPAC pipeline. A key cross-cutting theme is the aggressive use of non-redemption agreements and dilutive financing structures (e.g., Ribbon Acquisition Corp.) to secure trust funds and extend deadlines, highlighting persistent redemption pressure. On the operational M&A front, Hillman Solutions and HF Foods Group closed strategic bolt-on acquisitions, expanding into new markets (industrial fasteners and Canada, respectively), while NET Power advanced its Project Permian. The PlusAI merger stands out as the highest-value deal at an $800M pre-money valuation, though it remains pre-commercial. No significant period-over-period financial trends (e.g., revenue growth, margin compression) were available from the filings, as most are SPAC-related and lack operational history. The most critical development is the high approval rate (90.3%) for the GOWell Technology merger, suggesting strong shareholder alignment, contrasted by the multiple extension attempts by Andretti Acquisition Corp. II, indicating deal execution risk.

16 high priority 16 total filings
· daily

US Merger & Acquisition SEC Filings — September 02, 2026

The US M&A landscape on September 2, 2026, is characterized by a surge in SPAC activity, with three new IPOs (Inflection Point, Southern Cross, JATT III) raising over $395M, alongside a notable de-SPAC completion (D. Boral ARC/Exascale) marred by massive redemptions (96% of public shares). Deal execution risk is elevated, evidenced by one merger termination (Quantumsphere), multiple deadline extensions (Lakeshore, Blue Acquisition), and a delisting notice (Eureka). Strategic divestitures are trending, with INNOVATE and FiscalNote shedding assets to focus on core operations, while G-III's Marc Jacobs acquisition highlights a pivot to owned brands amid a 10% sales decline. Negative signals dominate: SPAC warrant delisting risk (ARC Group), a foreclosure (Chase General), and high redemptions in completed deals. However, opportunities exist in G-III's margin expansion (440 bps) and ROC's strategic acquisition, while the settlement in EGH's litigation removes a key hurdle. Overall, the market shows a bifurcation between well-capitalized strategic buyers and struggling SPACs facing regulatory and shareholder pressure.

17 high priority 17 total filings
· daily

US Merger & Acquisition SEC Filings — September 01, 2026

The September 1, 2026, filing cycle reveals a significant wave of M&A activity, with four major acquisitions closing on the same day (Korn Ferry/AMS, Ryman/Grande Lakes, Figure/Kiavi, Red Robin refranchising) and a fifth in advanced stages (Helix/Hornbeck). The deals span diverse sectors—talent consulting, hospitality, fintech, restaurants, and offshore energy—but share a common theme of strategic consolidation and deleveraging. Period-over-period data from the Hornbeck filing shows strong operational performance (revenue +12.3% YoY, net income +86.8% YoY), supporting the acquisition thesis. However, several filings also reveal financial strain: Ryman's acquisition is expected to dilute EPS and FFO per share, while Red Robin's refranchising is a debt-reduction play. SPAC activity remains tepid, with Andretti Acquisition Corp. II struggling to secure shareholder approval and Iron Horse Acquisition II Corp. providing only a minor customer win for its target. Two companies (Crinetics and NCS Multistage) filed charters reducing authorized shares to 1,000, strongly suggesting they are going private or executing reverse splits, which warrants close monitoring. Overall, the digest points to a market where acquirers are using cash and stock to scale, but near-term financial dilution and integration risks are key concerns.

10 high priority 10 total filings